Aran et al. suggest that CD5L is upregulated in hepatocellular carcinoma and promotes the proliferation and anti-apoptotic response of liver cancer cells by binding to HSPA5 (GRP78) [42]. Here, HSPA5 is linked to hepatocellular carcinoma.